Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis

Anas M Saad1, Nicholas Kassis2, Mohamed M Gad2

  • 1Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Abstract

Insights

Patients with atrial fibrillation (AF) undergoing MitraClip (MC) repair face higher risks of stroke and 30-day mortality. Optimization of stroke prevention strategies is crucial for this patient group.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Outcomes Research

Background:

  • Atrial fibrillation (AF) is a common comorbidity in patients undergoing cardiac procedures.
  • The impact of AF on short-term outcomes after percutaneous mitral valve repair with MitraClip (MC) is not well-defined.

Purpose of the Study:

  • To assess and compare short-term postprocedural outcomes between patients with and without AF who underwent MC.
  • To identify the association between AF and in-hospital stroke and mortality after MC.

Main Methods:

  • Retrospective cohort study using the Nationwide Readmissions Database (2014-2017).
  • Stratification of patients based on the presence of AF.
  • Multivariable logistic regression analyses to determine the association between AF and in-hospital stroke/mortality.

Main Results:

  • Nearly half (49.7%) of 15,570 MC patients had AF; these patients were older and more comorbid.
  • AF patients had significantly higher rates of in-hospital ischemic and hemorrhagic stroke compared to non-AF patients.
  • Adjusted analyses revealed AF was associated with increased in-hospital stroke (OR=2.096) but not in-hospital mortality. AF patients also experienced longer hospitalizations and higher 30-day readmission and mortality rates.

Conclusions:

  • Patients with AF undergoing MC repair have an elevated risk of in-hospital stroke and 30-day mortality.
  • These findings underscore the need for enhanced preprocedural optimization and stroke prevention strategies for AF patients undergoing MC.
  • Further research into tailored management for AF patients undergoing MitraClip is warranted.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
159
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
146
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
214
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
117
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
220
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
205